HelixoMetry, Inc. is a privately held, Silicon Valley based Intellectual Capital Portfolio
* FRACTOGENE PATENT PENDING *
Founder of Helixometry
tel: (408) 891-7187
Aug 1, 2002
FractoGene Patent Pending. Initial offerings outlined, first in a closely held manner.
FractoGene of HelixoMetry is marketed in 7 overlapping Business Models
"Seven Sisters":
(1) Translation Memory Company, Partnership / M/A
(2) "Big Pharma" Pharmaceutical Company, M/A
(3) "Big IT" Information Technology Company, Acquisition
Advantage: Capital strength and IT R&D readiness by Big IT. Surest path to leverage FractoGene patent. IT Companies can build & monopolize hardware. Overlaps with 1,4,5,6,7.
IBM (Talks started in March with Caroline Kovac, May 2002)
INTEL (Talks started in August with Andy Grove)
MICROSOFT (Talks started with ex-Chief Scientist Nathan Myhrvold in March 2002)
MOTOROLA (Intron repetition counter protected by FractoGene patent- an alternative for the biochip by Affymetrix)
SUN
APPLE
ORACLE
HEWLETT-PACKARD-COMPAQ
AGILENT TECHNOLOGIES
SGI
AMD
SAMSUNG
LOGITECH
SIEMENS
SITF
TELENOR
SK TELECOM
CANON
SONY
TOSHIBA
FUJITSU
MITSUBISHI
HITACHI
NEC
SANYO
FRENCH TELECOM
(4) Bioinformatics Company Cooperation / Partnership
(5) Genomics Data-Base Company, M/A / Partnership
(6) University R&D Center, M/A / Professorship / Directorship
(7) Regional Center Uniqueness Cooperation / Directorship